6.3 Dynamic Assessment of Fluid Responsiveness & Resuscitation Targets

ABIM Critical Care Medicine Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Orientation: Format, Blueprint & Study Strategy

1.1 ABIM Critical Care Medicine Exam: Format, Blueprint & Study Strategy

2 Chapter 2: Acute Respiratory Failure & ARDS

2.1 ARDS Definition, Pathophysiology & Phenotypes 2.2 Lung-Protective Mechanical Ventilation 2.3 Refractory ARDS: Prone Positioning, Neuromuscular Blockade & VV-ECMO

3 Chapter 3: Obstructive Airways, Pulmonary Vascular & Pleural Emergencies

3.1 Severe Asthma & COPD Exacerbations in the ICU 3.2 Massive & Submassive Pulmonary Embolism 3.3 Pulmonary Hypertension & Right Ventricular Failure in the ICU 3.4 Massive Hemoptysis, Complex Pleural Effusions & Thoracic Drainage

4 Chapter 4: Airway, Parenchymal & Nonthrombotic Pulmonary Emergencies

4.1 Airway Management, Upper-Airway Obstruction & Artificial-Airway Complications 4.2 Diffuse Alveolar Hemorrhage, Interstitial Lung Disease, Pulmonary Vasculitis & Noncardiogenic Edema 4.3 Severe Community-Acquired & Viral Pneumonia 4.4 Nonthrombotic Embolism (Air, Fat, Amniotic Fluid, Tumor, Septic) & Acute Chest Syndrome

5 Chapter 5: Mechanical Ventilation Modes, Dyssynchrony & Liberation

5.1 Mechanical Ventilator Modes & Advanced Breath Delivery 5.2 Patient-Ventilator Dyssynchrony & Waveform Analysis 5.3 Ventilator Liberation, Spontaneous Breathing Trials & Post-Extubation Support

6 Chapter 6: Shock Syndromes & Hemodynamic Principles

6.1 Shock Classification, Cellular Pathophysiology & Biomarkers 6.2 Hemodynamic Monitoring: Arterial Lines, CVP & Pulmonary Artery Catheter 6.3 Dynamic Assessment of Fluid Responsiveness & Resuscitation Targets

7 Chapter 7: Vasoactive Therapies & Mechanical Circulatory Support

7.1 Vasopressors & Inotropes: Pharmacology & Clinical Titration 7.2 Temporary Mechanical Circulatory Support: IABP, Impella & TandemHeart 7.3 Venoarterial ECMO (VA-ECMO) & Differential Hypoxemia 7.4 Post-Cardiac Arrest Care, Targeted Temperature Management & Neuroprognostication

8 Chapter 8: Acute Kidney Injury & Renal Replacement Therapy

8.1 KDIGO AKI Classification, Etiologies & Diagnostic Evaluation 8.2 Continuous Renal Replacement Therapy (CRRT) vs Intermittent Hemodialysis 8.3 Indications & Timing for RRT in Critical Illness: AKIKI & STARRT-AKI

9 Chapter 9: Electrolyte, Acid-Base & Endocrine Emergencies

9.1 Severe Dysnatremias: Hyponatremia, Hypernatremia & Osmotic Demyelination 9.2 Potassium, Calcium, Magnesium & Phosphate Disorders 9.3 Complex & Mixed Acid-Base Disorders: Boston vs Copenhagen vs Stewart 9.4 Endocrine Crises: DKA, HHS, Thyroid Storm, Myxedema Coma & Adrenal Crisis

10 Chapter 10: Glycemic Control, Hyperammonemia, Pituitary & Adrenal Disorders

10.1 ICU Glycemic Control & Severe Hypoglycemia 10.2 Non-Hepatic Hyperammonemia & Metabolic Encephalopathy 10.3 Pituitary Emergencies, Adrenal Excess & Critical Illness-Related Corticosteroid Insufficiency

11 Chapter 11: Acute Coronary Syndromes & Cardiac Arrhythmias

11.1 Acute Coronary Syndromes & Mechanical Complications of Myocardial Infarction 11.2 Critical Tachyarrhythmias: Atrial Fibrillation with RVR, VT & VF 11.3 Critical Bradyarrhythmias, Conduction Blocks & Temporary Cardiac Pacing

12 Chapter 12: Acute Heart Failure, Valvular & Pericardial Emergencies

12.1 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 12.2 Acute Valvular Regurgitation & Prosthetic Valve Emergencies 12.3 Pericardial Tamponade & Acute Aortic Syndromes

13 Chapter 13: Myocardial Disease, Hypertensive & Cardiac Device Emergencies

13.1 Fulminant Myocarditis, Stress & Peripartum Cardiomyopathy, and Hypertrophic Cardiomyopathy 13.2 Hypertensive Emergencies & Ruptured Abdominal Aortic Aneurysm 13.3 Implanted Cardiac Devices, LVAD Emergencies & Electrical Storm

14 Chapter 14: Sepsis & Systemic Infectious Diseases

14.1 Sepsis-3 Definitions & Surviving Sepsis Campaign 2026 Guidelines 14.2 Refractory Septic Shock & Adjunctive Therapies 14.3 Multidrug-Resistant Pathogens & Antimicrobial Stewardship in the ICU

15 Chapter 15: ICU-Acquired & Severe Focal Infections

15.1 Hospital-Acquired & Ventilator-Associated Pneumonia 15.2 Central Line-Associated Bloodstream Infections & Catheter-Associated UTIs 15.3 Intra-Abdominal Sepsis, Necrotizing Soft Tissue Infections & CNS Infections

16 Chapter 16: Focal, Special-Host & Systemic Infections

16.1 CNS Infections Beyond Bacterial Meningitis: Encephalitis, Brain Abscess & Epidural Abscess 16.2 Infections in the Immunocompromised Host, Tropical & Bioterror Infections 16.3 Infective Endocarditis, Device Infections & Other Focal Cardiovascular Infections 16.4 Antimicrobial Pharmacokinetics, Allergy, Toxicity & Infection Prevention 16.5 Gastrointestinal & Hepatobiliary Infections: Fulminant C. difficile, Typhlitis, CMV Colitis & Abscesses

17 Chapter 17: Neurocritical Care & Coma

17.1 Coma, Altered Mental Status & Acute Delirium in the ICU 17.2 Status Epilepticus & Non-Convulsive Status Epilepticus 17.3 Acute Ischemic Stroke & Intracranial Hemorrhage

18 Chapter 18: Cerebrovascular Syndromes, Encephalopathy & Withdrawal States

18.1 Cerebral Venous Sinus Thrombosis, PRES & Reversible Cerebral Vasoconstriction Syndrome 18.2 Alcohol & Sedative Withdrawal, Wernicke Encephalopathy & Drug-Induced Encephalopathy

19 Chapter 19: Intracranial Hypertension & Neuromuscular Weakness

19.1 Intracranial Pressure Monitoring, Cerebral Perfusion & Tiered ICP Management 19.2 Acute Neuromuscular Respiratory Failure, ICU-Acquired Weakness & Brain Death Determination

20 Chapter 20: Traumatic Brain Injury, Spinal Cord Injury & Toxin-Mediated Paralysis

20.1 Traumatic Brain Injury Management & Paroxysmal Sympathetic Hyperactivity 20.2 Acute Spinal Cord Injury, Neurogenic Shock & Autonomic Dysreflexia 20.3 Toxin-Mediated Paralysis & Neuromuscular Crises: Botulism, Tetanus, Tick Paralysis & Myasthenic Crisis

21 Chapter 21: Gastrointestinal, Hepatic & Abdominal Emergencies

21.1 Acute Upper & Lower Gastrointestinal Bleeding in the ICU 21.2 Acute Liver Failure & Severe Acute Pancreatitis 21.3 Abdominal Compartment Syndrome & Acute Mesenteric Ischemia

22 Chapter 22: Luminal GI Emergencies & Complications of Cirrhosis

22.1 Esophageal, Gastric & Bowel Emergencies: Perforation, Obstruction, Ogilvie Syndrome & Colonic Ischemia 22.2 Complications of Cirrhosis: Alcohol-Associated Hepatitis, Hepatorenal Syndrome & Pulmonary Vascular Syndromes

23 Chapter 23: Trauma, Burns & Perioperative Critical Care

23.1 Polytrauma Resuscitation, Damage Control & Massive Transfusion 23.2 Severe Burn Injury, Inhalation Injury & Environmental Emergencies 23.3 Perioperative Critical Care for High-Risk Surgical Patients

24 Chapter 24: Thoracic Trauma, Environmental Injury & Obstetric Critical Care

24.1 Thoracic Trauma: Flail Chest, Pulmonary Contusion, Great Vessel & Tracheobronchial Injury 24.2 Environmental Injury: Drowning, Diving, Altitude, Heat, Cold, Electrical & Radiation 24.3 Obstetric & Genitourinary Emergencies and the Physiology of Pregnancy

25 Chapter 25: Transplantation, Donor Management & Post-Cardiac Surgery Care

25.1 Solid Organ Transplant Recipients & Deceased Donor Management 25.2 Post-Cardiac Surgery Critical Care: Bleeding, Tamponade, Low Output & Vasoplegia

26 Chapter 26: Hematologic Emergencies, Toxicology, Critical Ultrasound & ICU Liberation

26.1 Hematologic Emergencies in the ICU: HIT, DIC, TMA & Anticoagulant Reversal 26.2 Critical Care Toxicology, Toxidromes & Specific Antidotes 26.3 Critical Care Point-of-Care Ultrasound (POCUS) 26.4 ICU Liberation, Analgosedation, Goals of Care & Critical Care Ethics

27 Chapter 27: Transfusion Medicine, Hematologic & Oncologic Disorders

27.1 Transfusion Medicine: Products, Thresholds, Reactions & Apheresis 27.2 Red and White Cell Disorders, Hemoglobinopathies, Factor Deficiencies & Hypercoagulable States 27.3 Oncologic Emergencies, Hematopoietic Cell Transplant Complications & Cellular Therapy Toxicity

28 Chapter 28: Clinical Pharmacology, Adverse Drug Reactions & Specific Poisonings

28.1 Pharmacokinetic Principles, Dose Adjustment & Drug Interactions in Critical Illness 28.2 Adverse Drug Reactions: Anaphylaxis, Severe Cutaneous Reactions & Hyperthermic Syndromes 28.3 Specific Poisonings: Sodium-Channel Blockers, Lithium, Valproate, Theophylline, Iron, Sulfonylureas & Methemoglobinemia

29 Chapter 29: Ethics, Research Methods, Administration & Abdominal Ultrasound

29.1 Advance Care Planning, Nonbeneficial Treatment, Informed Consent & Confidentiality 29.2 Critical Care Research Methods, Statistics, IRB Oversight & Quality Improvement 29.3 Abdominal, Vascular & Procedural Point-of-Care Ultrasound

6.3 Dynamic Assessment of Fluid Responsiveness & Resuscitation Targets

Key Takeaways Explain This Topic AI

Fluid responsiveness is defined as a 10% to 15% increase in stroke volume or cardiac output in response to an intravascular volume challenge, which occurs only when both right and left ventricles operate on the steep ascending limb of the Frank-Starling curve.

Heart-lung interactions under positive pressure ventilation induce cyclic changes in intrathoracic pressure that decrease right ventricular preload and increase afterload, creating downstream cyclic variations in left ventricular stroke volume.

Pulse pressure variation (PPV > 12-13%) and stroke volume variation (SVV > 10-12%) reliably predict fluid responsiveness only in fully passive mechanically ventilated patients without spontaneous breathing, with tidal volumes >= 8 mL/kg PBW, regular sinus rhythm, and normal chest wall compliance.

The passive leg raise (PLR) test creates a completely reversible, endogenous ~300 mL autotransfusion; a real-time increase in cardiac output or stroke volume >= 10% confirms fluid responsiveness even in spontaneously breathing patients and those with cardiac arrhythmias.

Fluid responsiveness must never be conflated with fluid tolerance; identifying responsiveness does not mandate fluid administration if the patient exhibits signs of organ congestion or elevated extravascular lung water (evaluated via VExUS scoring and lung ultrasound).

Last updated: October 2026

Frank-Starling Physiology: Preload Dependency vs. Independency

The fundamental goal of intravenous fluid administration in circulatory shock is to increase left ventricular stroke volume ( SV \text{SV} SV ), augment cardiac output, and improve systemic oxygen delivery to ischemic tissues. However, fluid administration achieves this goal only when the heart operates on the ascending limb of the Frank-Starling relationship.

The Frank-Starling law dictates that myocardial sarcomere stretch during end-diastole (preload) increases the affinity of troponin C for calcium and optimizes actin-myosin cross-bridge overlap, augmenting the force of myocardial contraction: Stroke Volume (SV)

▲
│ Preload Independent (Flat Plateau)
│ ┌────────────────────────────
│ / ▲
│ / │ Fluid administration causes
│ / │ edema, congestion, no SV gain
│ / ▼
│ / Preload Dependent
│ / (Steep Ascending Limb)
│ / ▲
│ / │ Fluid administration yields
│ / │ significant SV increase (>= 10-15%)
│ / ▼
└─────────┴──────────────────────────────────────►
Preload (Ventricular End-Diastolic Volume)

Preload Dependency (The Ascending Limb) : In this operating range, an increase in end-diastolic volume directly augments stroke volume. A patient is physiologically defined as fluid responsive if a standardized volume challenge ( 500 mL 500\text{ mL} 500 mL crystalloid or an endogenous autotransfusion) produces an increase in stroke volume or cardiac output of ≥ 10 % \ge 10\% ≥ 10% to 15 % 15\% 15% .

Preload Independency (The Flat Plateau) : When myocardial sarcomeres achieve maximal physiological stretch, further increases in end-diastolic volume fail to augment stroke volume. In this operating zone, any administered fluid cannot improve cardiac output; instead, it is sequestered entirely within the upstream venous and microvascular beds, elevating hydrostatic capillary filtration pressure, generating interstitial and pulmonary edema, and promoting venous congestion and multi-organ failure.

In unselected critically ill patients with acute circulatory failure, only approximately 50 % 50\% 50% of patients are fluid responsive . Administering intravenous fluids to the remaining non-responsive 50 % 50\% 50% provides zero hemodynamic benefit while directly driving iatrogenic morbidity. Consequently, clinicians must move beyond static filling pressures and employ dynamic physiological maneuvers.

Heart-Lung Interactions on Mechanical Ventilation

Dynamic parameters of fluid responsiveness exploit cyclic variations in cardiopulmonary hemodynamics induced by positive pressure mechanical ventilation.

Cardiopulmonary Mechanics During Positive Pressure Inflation

In a patient receiving positive pressure ventilation, each mechanical breath exerts distinct effects on right and left ventricular loading conditions:

Right Ventricle (RV) :

Inspiration : As the ventilator delivers positive inspiratory pressure, intrathoracic pressure ( I T P ITP I TP ) rises. This increase in I T P ITP I TP reduces the pressure gradient for systemic venous return (mean systemic filling pressure minus right atrial pressure: P m s − R A P P_{ms} - RAP P m s − R A P ), diminishing RV end-diastolic filling ( decreased RV preload ). Simultaneously, lung inflation expands alveoli and compresses alveolar microvessels, increasing transpulmonary pressure and pulmonary vascular resistance ( increased RV afterload ). The combination of reduced preload and increased afterload precipitously drops RV stroke volume, reaching its minimum at end-inspiration.

Expiration : As I T P ITP I TP falls during passive expiration, venous return resumes, RV preload is restored, RV afterload declines, and RV stroke volume increases.

Left Ventricle (LV) :

Because of pulmonary vascular transit time, the reduction in RV stroke volume that occurred during inspiration requires two to three cardiac cycles to traverse the pulmonary circulation and arrive at the left atrium. Consequently, the reduction in blood volume reaches the left ventricle during the expiratory phase of mechanical ventilation, causing a cyclic drop in LV end-diastolic volume ( decreased LV preload ) and a corresponding drop in LV stroke volume and arterial pulse pressure.

Conversely, during inspiration, the transient compression of pulmonary venous capacitance beds ("squeezing" of pulmonary alveolar blood into the left atrium) combined with a slight reduction in LV transmural afterload transiently augments LV preload, causing peak LV stroke volume to occur during mechanical inspiration.

Pulse Pressure Variation ( P P V PPV PP V ) and Stroke Volume Variation ( S V V SVV S VV )

In an arterial catheter system, pulse pressure (systolic minus diastolic pressure) is directly proportional to stroke volume and inversely proportional to arterial elastance ( P P ≈ S V / C a r t PP \approx SV / C_{art} PP ≈ S V / C a r t ). Pulse pressure variation ( P P V PPV PP V ) and stroke volume variation ( S V V SVV S VV ) quantify the magnitude of cyclic variation across a complete respiratory cycle:

P P V ( % ) = 100 × P P m a x − P P m i n ( P P m a x + P P m i n ) / 2 PPV (\%) = 100 \times \frac{PP_{max} - PP_{min}}{\left( PP_{max} + PP_{min} \right) / 2} PP V ( % ) = 100 × ( P P ma x + P P min ) /2 P P ma x − P P min

S V V ( % ) = 100 × S V m a x − S V m i n ( S V m a x + S V m i n ) / 2 SVV (\%) = 100 \times \frac{SV_{max} - SV_{min}}{\left( SV_{max} + SV_{min} \right) / 2} S VV ( % ) = 100 × ( S V ma x + S V min ) /2 S V ma x − S V min

Diagnostic Thresholds :

P P V > 12 % PPV > 12\% PP V > 12% to 13 % 13\% 13% reliably predicts that the patient is preload responsive.

S V V > 10 % SVV > 10\% S VV > 10% to 12 % 12\% 12% (measured via arterial pulse contour analysis or transesophageal echocardiography) confirms fluid responsiveness.

Values in the "gray zone" ( P P V 9 − 13 % PPV\ 9-13\% PP V 9 − 13% ) require confirmatory functional testing before fluid administration.

Prerequisites and Pitfalls of Dynamic Cardiopulmonary Indices

While P P V PPV PP V and S V V SVV S VV possess high diagnostic accuracy under controlled physiological conditions, they are invalid if specific prerequisites are not fulfilled:

Fully Controlled Mechanical Ventilation (No Spontaneous Breathing Efforts) : Spontaneous inspiratory efforts generate negative pleural pressure swings that reverse the intrathoracic pressure gradient, producing erratic and uninterpretable arterial variations. Patient-ventilator dyssynchrony generates false-positive elevations in P P V PPV PP V .

Tidal Volume ≥ 8 mL/kg \ge 8\text{ mL/kg} ≥ 8 mL/kg Predicted Body Weight (PBW) : Lung-protective ventilation in ARDS mandates tidal volumes of 6 mL/kg PBW 6\text{ mL/kg PBW} 6 mL/kg PBW . Small tidal volumes generate insufficient intrathoracic pressure swings to induce cyclic preload changes, producing false-negative P P V PPV PP V ( P P V < 13 % PPV < 13\% PP V < 13% in truly responsive patients).

Regular Cardiac Rhythm (Absence of Arrhythmias) : Atrial fibrillation, frequent premature ventricular contractions (PVCs), and frequent premature atrial contractions (PACs) induce beat-to-beat variations in stroke volume due to variable diastolic filling duration, completely invalidating P P V PPV PP V and S V V SVV S VV .

Normal Chest Wall and Lung Compliance : Severe chest wall rigidity, open thoracotomy, or extraordinarily stiff lungs (static compliance C r s < 30 mL/cmH 2 O C_{rs} < 30\text{ mL/cmH}_2\text{O} C rs < 30 mL/cmH 2 O ) blunt the transmission of airway pressure into the pleural and pericardial space, producing false-negative results.

Heart Rate to Respiratory Rate Ratio ( H R / R R ≥ 3.6 HR/RR \ge 3.6 H R / RR ≥ 3.6 ) : If the patient is tachycardic with slow ventilation, or bradycardic with rapid respiratory rates, fewer than 3-4 heartbeats occur per respiratory cycle, causing computational aliasing.

Absence of Acute Cor Pulmonale / Right Ventricular Failure : In patients with acute RV failure (massive PE, severe ARDS with RV strain), cyclic increases in RV afterload during mechanical inspiration induce profound cyclic reductions in RV output that mimic LV preload responsiveness, generating false-positive P P V PPV PP V . Administering fluids in this setting precipitates lethal RV dilation and cardiogenic collapse.

The Tidal Volume Challenge (TVC)

To overcome the limitation of low tidal volumes ( 6 mL/kg PBW 6\text{ mL/kg PBW} 6 mL/kg PBW ) in patients with ARDS, clinicians utilize the Tidal Volume Challenge :

While maintaining controlled ventilation, the tidal volume is transiently increased from 6 mL/kg 6\text{ mL/kg} 6 mL/kg to 8 mL/kg PBW 8\text{ mL/kg PBW} 8 mL/kg PBW for 1 1 1 to 2 minutes 2\text{ minutes} 2 minutes .

An absolute increase in P P V ≥ 3.5 % PPV \ge 3.5\% PP V ≥ 3.5% (or an increase in S V V ≥ 2.5 % SVV \ge 2.5\% S VV ≥ 2.5% ) highly reliably predicts fluid responsiveness, without exposing the patient to prolonged volutrauma.

The Passive Leg Raise (PLR) Test and End-Expiratory Occlusion

When spontaneous breathing efforts, low tidal volumes, or cardiac arrhythmias invalidate P P V PPV PP V and S V V SVV S VV , functional volume challenge maneuvers must be utilized.

The Passive Leg Raise (PLR) Test

The passive leg raise test is the gold-standard functional hemodynamic test. It represents a reversible, endogenous volume challenge that transfers venous blood from the lower extremities and splanchnic reservoir into the intrathoracic circulation:

Physiological Mechanism : Elevating the legs autotransfuses approximately 300 mL 300\text{ mL} 300 mL of blood into the right heart, acutely increasing mean systemic filling pressure and RV preload.

Bedside Technique :

The patient begins in a semi-recumbent position ( 45 ∘ 45^\circ 4 5 ∘ head-up, legs flat horizontal).

Using the automated bed mechanism (avoiding manual lifting of the legs, which can induce pain, sympathetic stimulation, or coughing), the trunk is laid completely flat ( 0 ∘ 0^\circ 0 ∘ ) while the lower limbs are simultaneously elevated to 45 ∘ 45^\circ 4 5 ∘ .

The maximal hemodynamic effect occurs rapidly, peaking at 60 60 60 to 90 seconds 90\text{ seconds} 90 seconds .

The patient is returned to the initial semi-recumbent position, and hemodynamics must return to baseline, verifying reversibility.

Measurement Requirements : The clinician must directly assess real-time stroke volume or cardiac output (using echocardiography aortic velocity-time integral [VTI], continuous arterial pulse contour analysis, or bioreactance). Pulse pressure and blood pressure changes are not reliable surrogates ; up to 40 % 40\% 40% of true fluid responders during a PLR test display no significant change in arterial blood pressure due to variable arterial elastance.

Diagnostic Threshold : A real-time increase in cardiac output or stroke volume ≥ 10 % \ge 10\% ≥ 10% during the leg raise defines fluid responsiveness.

Major Advantages : Valid in spontaneously breathing patients, patients receiving low tidal volumes ( 6 mL/kg 6\text{ mL/kg} 6 mL/kg ), patients with cardiac arrhythmias (atrial fibrillation), and patients with low respiratory compliance. Passive Leg Raise (PLR) Protocol:

Position 1: Semi-recumbent (45° head up, legs flat) ──► Baseline measurement
Position 2: Supine trunk (0° flat, legs 45° elevated) ──► Reversible ~300 mL autotransfusion

Peak effect at 60-90 sec: Cardiac Output increase >= 10% indicates responsiveness!

Position 3: Return to semi-recumbent (45° head up, legs flat) ──► Verify return to baseline
The End-Expiratory Occlusion (EEO) Test

In mechanically ventilated patients, performing a 15 15 15 -second end-expiratory pause halts the cyclic positive-pressure impediment to venous return. During the occlusion, venous return to the right heart is uninterrupted, transiently increasing cardiac preload.

Diagnostic Threshold : An increase in real-time cardiac output or stroke volume ≥ 5 % \ge 5\% ≥ 5% at the end of the 15-second occlusion indicates fluid responsiveness.

Clinical Application : Highly useful in patients with ARDS ventilated at 6 mL/kg PBW 6\text{ mL/kg PBW} 6 mL/kg PBW who do not meet P P V PPV PP V criteria, provided they do not make spontaneous breathing trigger attempts during the 15-second pause.

Fluid Tolerance vs. Responsiveness, Organ Congestion & the ROSE Model

One of the most critical clinical distinctions in modern critical care is that fluid responsiveness does not equate to fluid tolerance, nor does it mandate fluid administration .

Fluid Responsiveness : An objective physiological property of the heart: "Will stroke volume increase if volume is infused?"

Fluid Tolerance : The ability of the vascular bed and parenchymal organs to accommodate volume without developing pathological interstitial edema, pulmonary gas exchange degradation, or organ venous hypertension.

For example, a patient with severe ARDS ( PaO 2 / FiO 2 = 90 mmHg \text{PaO}_2/\text{FiO}_2 = 90\text{ mmHg} PaO 2 / FiO 2 = 90 mmHg ) and septic shock may have an underfilled left ventricle that increases stroke volume by 12 % 12\% 12% during a PLR test (fluid responsive). However, because of profound alveolar-capillary barrier disruption, infusing crystalloids will markedly increase extravascular lung water (EVLW), worsen pulmonary shunt, accelerate gas exchange failure, and prolong mechanical ventilation. In this patient, fluid tolerance is zero; volume should be withheld, and cardiac output supported via vasopressors and judicious inotropes.

Assessing Venous Congestion: The VExUS Score

To quantify fluid intolerance and organ venous congestion at the bedside, clinicians utilize the Venous Excess Ultrasound (VExUS) grading system, which integrates inferior vena cava (IVC) diameter with Doppler waveforms of three venous beds:

IVC Assessment : An IVC diameter < 2.0 cm < 2.0\text{ cm} < 2.0 cm excludes severe venous congestion. If the IVC is dilated ( ≥ 2.0 cm \ge 2.0\text{ cm} ≥ 2.0 cm ) with minimal collapsibility ( < 50 % < 50\% < 50% in spontaneous breathing, < 15 % < 15\% < 15% in mechanical ventilation), Doppler ultrasound is performed on downstream organs:

Hepatic Vein Doppler : Normal flow is predominantly systolic ( S > D S > D S > D ). As right atrial pressure rises, systolic forward flow decreases, vanishes, and eventually demonstrates systolic flow reversal ( S S S -wave above baseline).

Portal Vein Doppler : Normal portal flow is continuous with minimal cardiac modulation (pulsatility fraction < 30 % < 30\% < 30% ). As congestion propagates retrogradely, pulsatility surges; a pulsatility fraction ≥ 50 % \ge 50\% ≥ 50% indicates severe pulsatile venous congestion.

Intrarenal Venous Doppler : Normal intrarenal parenchymal flow is continuous throughout the cardiac cycle. Congestion converts flow into a discontinuous biphasic pattern (separate systolic and diastolic components) and ultimately a monophasic diastolic-only pattern .

VExUS Grade 3 (Severe Venous Congestion) : Dilated IVC ( ≥ 2.0 cm \ge 2.0\text{ cm} ≥ 2.0 cm ) combined with severe flow abnormalities in at least two venous beds. Grade 3 congestion independently predicts acute kidney injury secondary to renal compartment hypertension and impaired renal perfusion pressure ( RPP = MAP − CVP \text{RPP} = \text{MAP} - \text{CVP} RPP = MAP − CVP ).

The ROSE Conceptual Resuscitation Framework

Modern fluid stewardship is structured around the four distinct phases of the ROSE model :

Phase Clinical Objective Primary Resuscitation Actions Hemodynamic & Fluid Targets

R: Resuscitation Salvage / Immediate survival Rapid correction of profound shock; targeted crystalloid boluses ( 30 mL/kg 30\text{ mL/kg} 30 mL/kg or guided aliquots) and early norepinephrine Restore minimum perfusing MAP ≥ 65 mmHg \ge 65\text{ mmHg} ≥ 65 mmHg ; preserve life

O: Optimization Cellular rescue / Perfusion fine-tuning Implement dynamic fluid responsiveness tests (PLR, TVC); titrate vasopressors/inotropes; assess organ perfusion Maximize DO 2 \text{DO}_2 DO 2 ; lactate clearance > 20 % > 20\% > 20% at 2 − 4 h 2-4\text{ h} 2 − 4 h ; stop fluids if non-responsive

S: Stabilization Organ recovery / Homeostasis Zero fluid balance target; withhold maintenance fluids; treat underlying infection or injury Maintain perfusion; avoid positive fluid balance; prevent tissue edema

E: Evacuation De-resuscitation / Decanting Active negative fluid balance; elimination of accumulated fluid using loop diuretics or ultrafiltration Mobilize extravascular fluid; improve lung compliance; accelerate extubation

Comparison of Dynamic Fluid Responsiveness Modalities

Modality Maneuver / Mechanism Diagnostic Threshold Key Prerequisites Major Advantages Major Limitations / Pitfalls

Pulse Pressure Variation ( P P V PPV PP V ) Cyclic changes in arterial pulse pressure driven by positive pressure ventilation > 12 % > 12\% > 12% to 13 % 13\% 13% Controlled ventilation, no spontaneous breathing, V t ≥ 8 mL/kg PBW V_t \ge 8\text{ mL/kg PBW} V t ≥ 8 mL/kg PBW , sinus rhythm, normal compliance Continuous, automated on arterial line monitors Invalidated by spontaneous efforts, arrhythmias, ARDS low V t V_t V t , and RV failure

Stroke Volume Variation ( S V V SVV S VV ) Cyclic variation in LV stroke volume measured via pulse contour analysis or echo > 10 % > 10\% > 10% to 12 % 12\% 12% Same as P P V PPV PP V criteria Direct stroke volume metric Same physiological restrictions as P P V PPV PP V ; requires dedicated monitor calibration

Tidal Volume Challenge (TVC) Transient increase in V t V_t V t from 6 6 6 to 8 mL/kg PBW 8\text{ mL/kg PBW} 8 mL/kg PBW for 1 − 2 min 1-2\text{ min} 1 − 2 min Absolute increase in P P V ≥ 3.5 % PPV \ge 3.5\% PP V ≥ 3.5% (or S V V ≥ 2.5 % SVV \ge 2.5\% S VV ≥ 2.5% ) Passive ventilation, sinus rhythm Enables dynamic assessment in ARDS patients on low tidal volumes Requires temporary ventilator adjustment; invalid with spontaneous breathing

Passive Leg Raise (PLR) Test Reversible endogenous autotransfusion of ~300 mL blood by elevating legs to 45 ∘ 45^\circ 4 5 ∘ Cardiac output or stroke volume increase ≥ 10 % \ge 10\% ≥ 10% Must measure real-time CO or SV (not blood pressure!) Valid in spontaneous breathing, arrhythmias, low V t V_t V t , and low compliance Cannot rely on cuff or arterial BP; false negatives in severe intra-abdominal hypertension

End-Expiratory Occlusion (EEO) 15-second ventilator pause at end-expiration halting venous return impediment Cardiac output or stroke volume increase ≥ 5 % \ge 5\% ≥ 5% Mechanical ventilation; no spontaneous trigger efforts during pause Quick, highly repeatable at bedside without changing patient posture Requires sensitive real-time cardiac output monitor; patient must tolerate 15-sec pause

Note

Changes in arterial blood pressure (systolic, mean, or pulse pressure) cannot be substituted for real-time stroke volume or cardiac output measurement during a passive leg raise test. Arterial compliance varies widely among critically ill patients; up to 40 % 40\% 40% of genuine fluid responders display a robust increase in cardiac output without any detectable change in systemic arterial blood pressure.